ClinicalTrials.gov
public full text
Public Domain
Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.
This study will identify the level of serum Riboneuclease 1 in systemic lupus patients and compare between its level in lupus nephritis and non nephritis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Early creatinine dynamics for stratifying acute kidney injury trajectories in patients with systemic lupus erythematosus: an exploratory multicenter retrospective study.#630896
- Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)#152601
- Rib Fixation for Clinically Severe Rib Fractures From Trauma#908074
- Effect of Red Wine, White Wine and Beer on Contrast-Medium Induced Acute Kidney Injury#980751
- Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients#811859
Record · ID 1007701
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive